Brumm Joshua T — SEC insider filings

SEC reporting owner CIK 1528826. 26 insider filings on record with FilingPulse; latest filed 2026-09-18.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2020-09-18 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dyne Therapeutics, Inc. (DYN)CEO & President, Director22—31 legs · 1,393,187 sh · $26,679,31349
CRESCENT BIOPHARMA, INC. (CBIO)Chief Executive Officer, Director4—3 legs · 51,752 sh · $920,8424

Insider filings — Brumm Joshua T

FiledFormIssuerReported transactionsSource
2026-09-184CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 1,610 @ $17.90 · Sale (S): 7,837 @ $16.71EDGAR
2026-06-234CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 42,305 @ $17.99EDGAR
2025-12-174CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 45,117 · Grant/award (A): 10,000 · Grant/award (A): 180,467 (derivative) @ $0EDGAR
2025-12-104CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 345,672 (derivative) @ $0EDGAR
2024-03-124Dyne Therapeutics, Inc. (DYN)Option exercise (M): 153,931 @ $5.54 · Option exercise (M): 209,412 @ $5.54 · Sale (S): 202,238 @ $25.30 · Sale (S): 160,670 @ $26.72 · Sale (S): 435 @ $27.38 · Option exercise (M): 50,000 @ $5.54 · +7 moreEDGAR
2024-03-114Dyne Therapeutics, Inc. (DYN)Sale (S): 9,086 @ $25.85EDGAR
2024-03-014Dyne Therapeutics, Inc. (DYN)Option exercise (M): 5,520 @ $5.54 · Sale (S): 5,520 @ $27.50 · Option exercise (M): 94,480 @ $5.54 · Sale (S): 18,976 @ $28.25 · Sale (S): 74,090 @ $29.23 · Sale (S): 1,414 @ $29.70 · +3 moreEDGAR
2024-01-314Dyne Therapeutics, Inc. (DYN)Gift (G): 20,000 @ $0 · Gift (G): 1,500 @ $0EDGAR
2024-01-044Dyne Therapeutics, Inc. (DYN)Option exercise (M): 51,183 @ $1.03 · Sale (S): 15,382 @ $18.34 · Sale (S): 19,775 @ $19.03 · Sale (S): 16,026 @ $20.50 · Option exercise (M): 18,536 @ $1.03 · Option exercise (M): 200,000 @ $5.54 · +5 moreEDGAR
2023-12-124Dyne Therapeutics, Inc. (DYN)Sale (S): 7,585 @ $10.72EDGAR
2023-11-164Dyne Therapeutics, Inc. (DYN)Grant/award (A): 358,877 @ $0 · Grant/award (A): 139,750 (derivative) @ $0EDGAR
2023-09-204Dyne Therapeutics, Inc. (DYN)Sale (S): 12,032 @ $9.41EDGAR
2023-09-134Dyne Therapeutics, Inc. (DYN)Sale (S): 7,672 @ $10.41EDGAR
2023-06-124Dyne Therapeutics, Inc. (DYN)Gift (G): 20,000 @ $0 · Gift (G): 1,800 @ $0 · Option exercise (M): 30,088 @ $1.03 · Sale (S): 46,811 @ $13.15 · Sale (S): 14,189 @ $13.47 · Option exercise (M): 76,582 @ $1.03 · +6 moreEDGAR
2023-03-154Dyne Therapeutics, Inc. (DYN)Sale (S): 7,318 @ $13.33EDGAR
2022-12-134Dyne Therapeutics, Inc. (DYN)Grant/award (A): 144,000 @ $0 · Sale (S): 3,322 @ $10.87 · Grant/award (A): 222,000 (derivative) @ $0EDGAR
2022-10-114Dyne Therapeutics, Inc. (DYN)Option exercise (M): 14,200 @ $1.03 · Sale (S): 14,200 @ $13.37 · Option exercise (M): 195,800 @ $1.03 · Sale (S): 195,800 @ $12.46 · Gift (G): 13,000 @ $0 · Gift (G): 2,500 @ $0 · +2 moreEDGAR
2022-09-214Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 11,836 @ $13.70EDGAR
2022-09-154Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 3,480 @ $14.05EDGAR
2022-07-064Dyne Therapeutics, Inc. (DYN)Grant/award (A): 24,118 @ $0 · Disposition to issuer (D): 10,963 @ $8.24 · Grant/award (A): 153,931 (derivative) @ $0 · Grant/award (A): 78,386 (derivative) @ $0EDGAR
2022-06-154Dyne Therapeutics, Inc. (DYN)Disposition to issuer (D): 3,540 @ $4.95EDGAR
2022-03-144Dyne Therapeutics, Inc. (DYN)Sale (S): 3,384 @ $8.73EDGAR
2021-12-144Dyne Therapeutics, Inc. (DYN)Grant/award (A): 118,190 @ $0 · Grant/award (A): 177,285 (derivative) @ $0EDGAR
2021-10-044Dyne Therapeutics, Inc. (DYN)Gift (G): 3,500 @ $0EDGAR
2021-09-224Dyne Therapeutics, Inc. (DYN)Sale (S): 3,425 @ $15.61 · Sale (S): 4,584 @ $16.11EDGAR
2020-09-184Dyne Therapeutics, Inc. (DYN)Grant/award (A): 107,027 @ $0 · Grant/award (A): 320,781 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1528826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs